Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-11, Stock:PFE, The news for the past five days is as follows:
2018-09-04: NEWS1: Pfizer Prices $5bln Debt Offering.NEWS2: Pfizer Prices $5bln Debt Offering.NEWS3: Mylan Suffers Several Setbacks: What's in Store in 2H18?.NEWS4: Mylan Suffers Several Setbacks: What's in Store in 2H18?.NEWS5: Better Buy: Pfizer Inc. vs. Eli Lilly and Company.NEWS6: Better Buy: Pfizer Inc. vs. Eli Lilly and Company.NEWS7: TREASURIES-Yields rise as investors prepare for corporate debt supply.NEWS8: Better Buy: Pfizer Inc. vs. Eli Lilly and Company.NEWS9: Mylan Suffers Several Setbacks: What&apos;s in Store in 2H18?.NEWS10: Pfizer says getting ready for Brexit will cost $100m.NEWS11: Pfizer Estimates Brexit Costs at $100 Million as Talks Drag.NEWS12: Pfizer Estimates Brexit Costs at $100 Million as Talks Drag On.
2018-09-05: NEWS1: [$$] SpringWorks Therapeutics Names Saqib Islam as CEO.NEWS2: Top Analyst Reports for Pfizer, Salesforce & ADP.NEWS3: Top Analyst Reports for Pfizer, Salesforce & ADP.NEWS4: Top Analyst Reports for Pfizer, Salesforce & ADP.NEWS5: Why Sangamo Therapeutics Stock Is Down More than 22% Today.NEWS6: HDV, PFE, CSCO, MCD: Large Outflows Detected at ETF.NEWS7: HDV, PFE, CSCO, MCD: Large Outflows Detected at ETF.NEWS8: Shire plc (SHPG) Ex-Dividend Date Scheduled for September 06, 2018.NEWS9: Shire plc (SHPG) Ex-Dividend Date Scheduled for September 06, 2018.NEWS10: Health Care Sector Update for 09/05/2018: HSGX, PRQR, NVS, AGIO, PFE.NEWS11: Health Care Sector Update for 09/05/2018: HSGX, PRQR, NVS, AGIO, PFE.NEWS12: Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata.NEWS13: 3 Biotech Stocks Ready to Burn Up.NEWS14: Pfizer Gets Breakthrough Therapy Designation From FDA For PF-06651600.NEWS15: Pfizer Gets Breakthrough Therapy Designation From FDA For PF-06651600.NEWS16: Pfizer Prices $5,000,000,000 Debt Offering.
2018-09-06: NEWS1: [$$] SpringWorks Joins BeiGene in Cancer Drug Collaboration.NEWS2: Zoetis: Livestock, Companion Animal Products Continue to Deliver.NEWS3: Thursday's ETF with Unusual Volume: IYH.NEWS4: Thursday's ETF with Unusual Volume: IYH.NEWS5: These Hospital Systems Are Aiming To Undercut Biotechs, Drugmakers.NEWS6: Pfizer’s PF-06651600 Receives a Breakthrough Therapy Designation.NEWS7: Pfizer's Skin Disease Drug Gets Breakthrough Therapy Status.NEWS8: Pfizer's Skin Disease Drug Gets Breakthrough Therapy Status.NEWS9: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS10: Large Cap Pharma Stocks Staging a Comeback in Second Half.NEWS11: Large Cap Pharma Stocks Staging a Comeback in Second Half.NEWS12: Sangamo's Zinc Fingers Fail Again. Time to Walk Away?.NEWS13: Sangamo's Zinc Fingers Fail Again. Time to Walk Away?.NEWS14: Dow Movers: PFE, CSCO.NEWS15: Dow Movers: PFE, CSCO.NEWS16: Pfizer&apos;s Skin Disease Drug Gets Breakthrough Therapy Status.NEWS17: The Zacks Analyst Blog Highlights: Pfizer, Salesforce, ADP, General Motors and Southwest Airlines.NEWS18: The Zacks Analyst Blog Highlights: Pfizer, Salesforce, ADP, General Motors and Southwest Airlines.NEWS19: Large Cap Pharma Stocks Staging a Comeback in Second Half.NEWS20: The Zacks Analyst Blog Highlights: Pfizer, Salesforce, ADP, General Motors and Southwest Airlines.NEWS21: Sangamo&apos;s Zinc Fingers Fail Again. Time to Walk Away?.NEWS22: 3 Top Big Pharma Stocks to Buy Now.NEWS23: 3 Top Big Pharma Stocks to Buy Now.NEWS24: Walgreens to offer Auvi-Q as EpiPen shortage challenges parents.NEWS25: Walgreens to offer Auvi-Q as EpiPen shortage challenges parents.NEWS26: Lilly's Elanco unit expects IPO to raise up to $1.45 bln.NEWS27: 3 Top Big Pharma Stocks to Buy Now.NEWS28: Date rape drug test allows women to discreetly check for spiked drinks with a few drops.NEWS29: [$$] Big Pharma Catches Up With Biotech.
2018-09-07: NEWS1: Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS2: Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS3: AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status.NEWS4: AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status.NEWS5: Allergan Launches the SkinMedica Lumivive System.NEWS6: Pharma Stock Roundup: NVS&apos; Sandoz Deal, Pipeline Updates at AZN & Others in Focus.NEWS7: What Zoetis’s Valuation Trend Indicates.NEWS8: AstraZeneca&apos;s Asthma Drug Gets Breakthrough Therapy Status.NEWS9: Your first trade for Friday, Sept 7.NEWS10: Analysts Are Bullish on Zoetis Stock.NEWS11: Lilly, Teva, Pfizer & Others Await FDA Decisions in September.NEWS12: Dow 30 Stock Roundup: Coca-Cola Buys Costa, DowDuPont Earnings Impress.NEWS13: Analyzing Zoetis’s Gross Margin Trend.NEWS14: Why Exact Sciences Corporation Stock Rocketed Higher in August.NEWS15: Why Exact Sciences Corporation Stock Rocketed Higher in August.NEWS16: Why Exact Sciences Corporation Stock Rocketed Higher in August.
2018-09-10: NEWS1: Apple, Snap Weak Again; Will This Sector Help Dow Beat Nasdaq In Q3?.NEWS2: Monday's ETF with Unusual Volume: XRLV.NEWS3: Monday's ETF with Unusual Volume: XRLV.NEWS4: See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks.NEWS5: See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks.NEWS6: Novartis a Top Ranked SAFE Dividend Stock With 3.6% Yield.NEWS7: Novartis a Top Ranked SAFE Dividend Stock With 3.6% Yield.NEWS8: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.NEWS9: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.NEWS10: Exelixis' Cabometyx Recommended by NCCN for All Types of RCC.NEWS11: Exelixis' Cabometyx Recommended by NCCN for All Types of RCC.NEWS12: The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson.

Answer: Rise